Results of a randomized, placebo-controlled, first-in-human trial of topical CY-002 in patients with cutaneous warts.
Pagan L, Yfanti C, Rijneveld R, Todd M, Jongste P, Feijen JJ, Klaassen ES, Bouwes Bavinck JN, Struijk L, de Koning MNC, Prestegarden L, Niemeyer-van der Kolk T, van Poelgeest MIE, Rissmann R.
Pagan L, et al. Among authors: rijneveld r.
J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e773-e775. doi: 10.1111/jdv.18291. Epub 2022 Jun 14.
J Eur Acad Dermatol Venereol. 2022.
PMID: 35699238
Clinical Trial.
No abstract available.